BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32742457)

  • 1. Risk factors associated with Para-Aortic Lymph Node Failure after pelvic irradiation in patients with Cervical Cancer.
    Wang W; Wang D; Liu X; Zhou Y; Ma J; Hou X; Hu K; Zhang F
    J Cancer; 2020; 11(17):5099-5105. PubMed ID: 32742457
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylactic Extended-Field Irradiation for Patients With Cervical Cancer Treated With Concurrent Chemoradiotherapy: A Propensity-Score Matching Analysis.
    Wang W; Liu X; Meng Q; Zhang F; Hu K
    Int J Gynecol Cancer; 2018 Oct; 28(8):1584-1591. PubMed ID: 30153215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Risk Factor for Para-Aortic Lymph Node Recurrence After Definite Pelvic Radiotherapy in Stage IIIB Cervical Cancer.
    Zhang G; Wang C; Ma C; Miao L; He F; Fu C
    Technol Cancer Res Treat; 2022; 21():15330338221141541. PubMed ID: 36426576
    [No Abstract]   [Full Text] [Related]  

  • 4. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20.
    Rotman M; Pajak TF; Choi K; Clery M; Marcial V; Grigsby PW; Cooper J; John M
    JAMA; 1995 Aug; 274(5):387-93. PubMed ID: 7616634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic Extended-Field Irradiation Versus Pelvic Irradiation in Patients With Cervical Cancer With 2018 FIGO Stage IIIC1 Disease.
    Wang W; Meng Q; Zhou Y; Hu K; Zhang F; Qiu J; Hou X; Lian X; Yan J; Liu Z; Sun S; Ma J; Liu X
    Pract Radiat Oncol; 2023; 13(5):e409-e415. PubMed ID: 37075837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic Extended-Field Irradiation in Patients With Cervical Cancer: A Literature Review.
    Wang W; Zhou Y; Wang D; Hu K; Zhang F
    Front Oncol; 2020; 10():579410. PubMed ID: 33123482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomograms predicting survival and patterns of failure in patients with cervical cancer treated with concurrent chemoradiotherapy: A special focus on lymph nodes metastases.
    Wang W; Liu X; Meng Q; Zhang F; Hu K
    PLoS One; 2019; 14(4):e0214498. PubMed ID: 30986236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does postoperative prophylactic irradiation of para-aortic lymph nodes reduce the risk of recurrence in uterine cervical cancer with positive pelvic lymph nodes?
    Yoshida K; Kajiyama H; Yoshihara M; Ikeda Y; Yoshikawa N; Nishino K; Utsumi F; Niimi K; Suzuki S; Kikkawa F
    Int J Clin Oncol; 2019 May; 24(5):567-574. PubMed ID: 30612268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escalated radiation and prophylactic extended field nodal irradiation are beneficial for FIGO IIIB cervical cancer patients' prognosis.
    Meng Q; Wang W; Liu X; Hou X; Lian X; Sun S; Yan J; Liu Z; Miao Z; Hu K; Zhang F
    Radiat Oncol; 2018 Nov; 13(1):223. PubMed ID: 30453993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of elective para-aortic lymph node irradiation in patients with locally advanced cervical cancer.
    Yap ML; Cuartero J; Yan J; Pintilie M; Fyles A; Levin W; Manchul L; Milosevic M
    Clin Oncol (R Coll Radiol); 2014 Dec; 26(12):797-803. PubMed ID: 25194726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Characteristics and Survival of Patients with Mesorectum Metastatic Lymph Nodes from Cervical Cancer.
    Wang W; Liu X; Zhang F; Hu K
    Cancer Manag Res; 2019; 11():10401-10408. PubMed ID: 31849529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic extended-field irradiation with concurrent chemotherapy for pelvic lymph node-positive cervical cancer.
    Oh J; Seol KH; Lee HJ; Choi YS; Park JY; Bae JY
    Radiat Oncol J; 2017 Dec; 35(4):349-358. PubMed ID: 29262671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome of extended-field irradiation vs. pelvic irradiation using intensity-modulated radiotherapy for cervical cancer.
    Ouyang Y; Wang Y; Chen K; Cao X; Zeng Y
    Oncol Lett; 2017 Dec; 14(6):7069-7076. PubMed ID: 29344136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic lower para-aortic irradiation using intensity-modulated radiotherapy mitigates the risk of para-aortic recurrence in locally advanced cervical cancer: A 10-year institutional experience.
    Lee J; Lin JB; Chang CL; Jan YT; Sun FJ; Wu MH; Chen YJ
    Gynecol Oncol; 2017 Jul; 146(1):20-26. PubMed ID: 28457584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose, prophylactic, extended-field, intensity-modulated radiotherapy plus concurrent weekly cisplatin for patients with stage IB2-IIIB cervical cancer, positive pelvic lymph nodes, and negative para-aortic lymph nodes.
    Liang JA; Chen SW; Hung YC; Yeh LS; Chang WC; Lin WC; Chang YY
    Int J Gynecol Cancer; 2014 Jun; 24(5):901-7. PubMed ID: 23975081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of primary para-aortic lymphadenectomy on distant failure in locally advanced cervical cancer patients treated in the era of image-guided adaptive brachytherapy.
    Chargari C; Mazeron R; Dunant A; Gouy S; Petit C; Maroun P; Uzan C; Annede P; Bentivegna E; Balleyguier C; Genestie C; Pautier P; Leary A; Lhomme C; Deutsch E; Morice P; Haie-Meder C
    Clin Exp Metastasis; 2016 Dec; 33(8):775-785. PubMed ID: 27530648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic surgical staging in cervical cancer--preliminary experience among Chinese.
    Chu KK; Chang SD; Chen FP; Soong YK
    Gynecol Oncol; 1997 Jan; 64(1):49-53. PubMed ID: 8995546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maximum Standardized Uptake Value of Pelvic Lymph Nodes in [18F]-Fluorodeoxyglucose Positron Emission Tomography Is a Prognostic Factor for Para-Aortic Lymph Node Recurrence in Pelvic Node-Positive Cervical Cancer Treated With Definitive Chemoradiotherapy.
    Kim DH; Kim WT; Bae JS; Ki YK; Park D; Suh DS; Kim KH; Lee JH; Lee JY; Jeon HS; Nam JH
    Int J Gynecol Cancer; 2016 Sep; 26(7):1274-80. PubMed ID: 27465890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
    Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ
    Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the efficacy of prophylactic extended field irradiation in the concomitant chemoradiotherapy treatment of locally advanced cervical cancer, stage IIIB in the 2018 FIGO classification.
    Meng Q; Liu X; Wang W; Hou X; Lian X; Sun S; Yan J; Liu Z; Miao Z; Hu K; Zhang F
    Radiat Oncol; 2019 Dec; 14(1):228. PubMed ID: 31842919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.